Liberal Transfusion Strategy May Avert Unfavorable Neurological Outcome

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 11, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Oct. 11, 2024 -- For patients with acute brain injury, a liberal transfusion strategy is associated with a lower risk for having an unfavorable neurological outcome, according to a study published online Oct. 9 in the Journal of the American Medical Association to coincide with the annual congress of the European Society of Intensive Care Medicine, held from Oct. 5 to 9 in Barcelona, Spain.

Fabio Silvio Taccone, M.D., Ph.D., from the Université Libre de Bruxelles in Brussels, and colleagues examined the impact of two different hemoglobin thresholds to guide red blood cell transfusions on neurological outcome in patients with acute brain injury in a trial conducted in 72 intensive care units across 22 countries. A total of 850 patients were randomly assigned to undergo a liberal or restrictive transfusion strategy over a 28-day period (transfusions triggered by hemoglobin <9 or <7 g/dL, respectively [408 and 442 patients]).

The liberal and restrictive transfusion strategy groups received a median of two and zero units of blood, respectively. The researchers found that 62.6 and 72.6 percent of patients in the liberal and restrictive strategy groups, respectively, had unfavorable neurological outcome at 180 days after randomization (adjusted relative risk, 0.86). Across prespecified subgroups, the effect of transfusion thresholds on neurological outcome at 180 days was consistent. Overall, 8.8 and 13.5 percent of patients in the liberal and restrictive strategy groups, respectively, had at least one cerebral ischemic event (relative risk, 0.65).

"Our findings substantially expand the existing evidence in relation to transfusion thresholds for patients in the intensive care unit with an acute brain injury," the authors write.

Abstract/Full Text

Editorial

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords